← Browse by Condition
Medical Condition

recurrent hepatocellular carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05103904 Phase 2
Recruiting

Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

Enrollment
19 pts
Location
United States
Sponsor
Emory University
View Trial →